Publications

Undisclosed HIV infection and antiretroviral therapy use in the Kenya AIDS indicator survey 2012: relevance to national targets for HIV diagnosis and treatment.
AIDS 2016 Nov;30(17):2685-2695
aDivision of Global HIV and Tuberculosis, Center for Global Health, US Centers for Disease Control and Prevention, Nairobi bMinistry of Health, National AIDS and STI Control Programme, Nairobi, Kenya cGlobal Health Sciences, University of California San Francisco, San Francisco, California, USA dMinistry of Health, National Public Health Laboratory Services, Nairobi, Kenya eDivision of Clinical Pharmacology, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa. *Members of the KAIS Study Group are listed in the Acknowledgments section.



Molecular Evidence of Sexual Transmission of Ebola Virus.
N Engl J Med 2015 Dec 14;373(25):2448-54. Epub 2015 Oct 14.
From the Center for Genome Sciences (S.E.M., J.R.K., J.T.L., M.R.W., K.P., M.S.-L., G.P.) and Diagnostic Systems Division (R.J.S.), U.S. Army Medical Research Institute of Infectious Diseases, and the Division of Clinical Research, Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH) (J.P., L.E.H., J.H.K.) - all in Frederick, MD; the Ministry of Health and Social Welfare (T.G.N., S.B.S., M.B., F.N.K.) and the World Health Organization (WHO) (G.J.D.-W., R.M.), Monrovia, and the Liberian Institute for Biomedical Research, Charlesville (L.F., F.T., F.B.) - all in Liberia; WHO, Geneva (T.C.-L., A.G., P.F.); the Centers for Disease Control and Prevention, Atlanta (A.C., B.W.H., U.S., D.J.B., A.S.L., D.E.W., T.L., S.T.N., K.M.D.C.); Illumina, San Diego, CA (G.P.S., S.M.G.); WHO, New Delhi, India (S.A.S); Rocky Mountain Laboratories, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH, Hamilton, MT (E.W., N.D., V.J.M., D.S.); Naval Medical Research Unit 3, Cairo (J.W.D.); and the Foundation Mérieux, Washington, DC (J.F.).



Prevalence and incidence of HIV infection, trends, and risk factors among persons aged 15-64 years in Kenya: results from a nationally representative study.
J Acquir Immune Defic Syndr 2014 May;66 Suppl 1:S13-26
*The National AIDS and Sexually Transmitted Infection (STI) Control Programme, Ministry of Health, Nairobi, Kenya; †Kenya National Bureau of Statistics, Nairobi, Kenya; ‡National Public Health Laboratory Services, Ministry of Health, Nairobi, Kenya; §The National Council for Population and Development, Nairobi, Kenya; ‖National AIDS Control Council, Nairobi, Kenya; ¶Kenya Medical Research Institute, Nairobi, Kenya; #Global Health Sciences, University of California, San Francisco, San Francisco, CA; **Ministry of Health, Nairobi, Kenya; and ††Division of Global HIV/AIDS, Center for Global Health, US Centers for Disease Control and Prevention, Nairobi, Kenya.

Tuberculosis and HIV at the national level in Kenya: results from the Second Kenya AIDS Indicator Survey.
J Acquir Immune Defic Syndr 2014 May;66 Suppl 1:S106-15
*National AIDS and Sexually Transmitted Infection (STI) Control Programme, Ministry of Health, Nairobi, Kenya; †Divison of Global HIV/AIDS, Center for Global health, US Centers for Disease Control and Prevention, Nairobi, Kenya; and ‡Global Health Sciences, University of California, San Francisco, San Francisco, CA.

Antiretroviral treatment scale-up among persons living with HIV in Kenya: results from a nationally representative survey.
J Acquir Immune Defic Syndr 2014 May;66 Suppl 1:S116-22
*Kenya Field Epidemiology and Laboratory Training Programme, Ministry of Health, Nairobi, Kenya; †Global Health Sciences, University of California, San Francisco, San Francisco, CA; ‡Division of Global HIV/AIDS Center for Global Health, Centers for Disease Control and Prevention, Nairobi, Kenya; §National AIDS and Sexually Transmitted Infection (STI) Control Programme, Ministry of Health, Nairobi, Kenya; and ‖National Public Health Laboratories Services, Ministry of Health, Nairobi, Kenya.

Kenya AIDS Indicator Surveys 2007 and 2012: implications for public health policies for HIV prevention and treatment.
J Acquir Immune Defic Syndr 2014 May;66 Suppl 1:S130-7
*National AIDS and Sexually Transmitted Infection (STI) Programme, Ministry of Health, Nairobi, Kenya; †Division of Global HIV/AIDS, Center for Global Health, US Centers for Disease Control and Prevention, Nairobi, Kenya; ‡Global Health Sciences, University of California, San Francisco, San Francisco, CA; §The Joint United Nations Program on HIV/AIDS, Nairobi, Kenya; ‖National Council for Population and Development, Nairobi, Kenya; and ¶Ministry of Health, Nairobi, Kenya.


Joseph Adera Odhiambo, 1954-2012 [Obituary].
Int J Tuberc Lung Dis 2013 Jun;17(6):852
United States Centers for Disease Control and Prevention (CDC), Nairobi, Kenya, On behalf of The United States CDC-Kenya; The United States Agency for International Development-Kenya; The Kenya Ministry of Public Health and Sanitation, Division of Leprosy, Tuberculosis and Lung Disease; and the Kenya Medical Research Institute.


HIV prevalence and associated risk factors among individuals aged 13-34 years in Rural Western Kenya.
PLoS One 2009 Jul 31;4(7):e6470. Epub 2009 Jul 31.
Division of HIV/AIDS Prevention, US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.


Adverse Events in HIV-Infected Persons Receiving Antiretroviral Drug Regimens in a Large Urban Slum in Nairobi, Kenya, 2003-2005.
J Int Assoc Physicians AIDS Care (Chic) 2007 Sep 19;6(3):206-9. Epub 2007 Jul 19.
Global AIDS Program, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia 30333, USA.


Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners.
Am J Respir Crit Care Med 2004 Sep 10;170(6):673-9. Epub 2004 Jun 10.
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, United Kingdom.

Stable incidence rates of tuberculosis (TB) among human immunodeficiency virus (HIV)-negative South African gold miners during a decade of epidemic HIV-associated TB.
J Infect Dis 2003 Oct 3;188(8):1156-63. Epub 2003 Oct 3.
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.



OF